1. Home
  2. Our Firm
  3. News
  4. Guggenheim Securities Hires Biotech Analyst William Tanner in Expansion of Healthcare Coverage

Our Firm

April 17, 2015

Guggenheim Securities Hires Biotech Analyst William Tanner in Expansion of Healthcare Coverage

NEW YORK – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, today announced the hiring of William Tanner as a Managing Director and senior biotech research analyst.

Mr. Tanner will start work at Guggenheim in May 2015 in the firm’s New York office.

“Bill brings a wealth of biotech experience, in both investment and academic research, to our experienced and highly acclaimed healthcare team,” said Matthew Johnson, Senior Managing Director and Head of Equities at Guggenheim Securities. “Bill will join a healthcare research team that includes, on the equities side, Tony Butler in biopharmaceuticals and Louise Chen in specialty pharmaceuticals, and, on the government policy side, Rick Weissenstein in healthcare policy analysis in Washington.”

“Bill’s hiring is part of a highly-focused recent expansion of our research capabilities in such key sectors as tech-media-telecom, consumer, energy, and financial services,” said John Hervey, Senior Managing Director and Director of Research at Guggenheim Securities. “The goal is to continue to enhance our ability to help our clients achieve outstanding investment results.”

Mr. Tanner has worked nearly 20 years as a biotech analyst, including senior analyst roles at Leerink Swann and SG Cowen.

He holds a Bachelor of Science degree and a PhD in Physiology, both from Texas A&M University, as well as an MBA from Washington University’s Olin School of Business. Before embarking on his investment research career, Mr. Tanner worked as a post-doctoral research fellow at Monsanto Co. and as an NIH National Research Service Award fellow at Washington University School of Medicine.


About Guggenheim Partners

Guggenheim Partners is a global investment and advisory firm with more than $220 billion in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With over 2,500 professionals based in more than 25 offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity. We invite you to learn more about our expertise and values by visiting GuggenheimPartners.com and following us on Twitter at twitter.com/guggenheimptnrs.



May 16, 2018

Guggenheim 2Q Fixed-Income Outlook: Preparing for Long-Awaited Choppier Markets

NEW YORK, NY –  Guggenheim Investments, the global asset management and investment advisory business of Guggenheim Partners, today provided its Second Quarter 2018 Fixed-Income Outlook, “Positioned for Choppier Waters.”

Read More

May 11, 2018

Guggenheim Partners Impact Report

The second edition of the impact report highlights our accomplishments in the areas of social impact and sustainable business practices.

Read Report

May 03, 2018

Guggenheim Securities Hires Mandar Vadhavkar to Expand Healthcare Investment Banking Group

Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Mandar Vadhavkar will join the firm as a Senior Managing Director in the firm’s Healthcare investment banking group, with a focus on advising companies in the healthcare services sector.

Read More



© 2018 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.